GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nautilus Biotechnology NAUT · USD

Health Care · US listing · 🇺🇸 United States

Compare

2.38

+6.73%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Nautilus Biotechnology

Our reporting

Next results

25 Feb 2027

Due on 25 Feb 2027. Analysts expect earnings of -0.15 a share on revenue of $262,500.

Past results

Reported against what analysts expected

27 Oct 202628 Jul 202628 Apr 202626 Feb 202627 Oct 202531 Jul 2025
Earnings per share-0.12-0.11-0.12-0.11-0.11-0.12
Forecast-0.14-0.14-0.14-0.14-0.15-0.15
Revenue$234,000$190,000————
Forecast$206,250$100,000$250,000$1.3m——

Key events

  1. 10 Jun 20211-to-1 reverse split
  2. 7 Aug 2020Listed

Nautilus Biotechnology in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.